Simon Arnett Jones - Curriculum Vitae#


EDUCATION
  • 1994 PhD Biochemistry, University of Bristol
  • 1990 BSc Applied Biological Sciences, Bristol Polytechnic

ACTIVE GRANTS (total income >£16M)
  • 2015 - 2021 Versus Arthritis Programme Grant. £907,778. How do cytokines signalling through the transcription factors STAT1 and STAT3 determine the course of synovial inflammation? SA Jones (PI), NM Williams, GW Jones, EH Choy, AS Williams, VB O’Donnell
  • 2020 - 2022 Mestag Therapeutics. Novel targeting of cytokine receptors. £347,000. SA Jones
  • 2018 - 2022 GSK. £357,572. IL-27 gene therapy: SA Jones (PI), GW Jones
  • 2019 - 2023 Systems Immunity/Monash University Joint PhD Scheme. £90,000. Cytokine control of disease heterogeneity in synovitis. SA Jones (PI), T Tiganis, SM Turner, NM Williams

RECOGNITION
  • Grant panels
  • Royal Irish Academy
  • Early Entry Grant Panel (2008)
  • Versus Arthritis (Arthritis Research UK)
  • Research Sub-Committee (2011-16; Vice Chair 2015)
  • Programme Grant Outline Panel (2015, 2016)
  • USER Group (Lay panel; 2015, 2016)
  • Joint Cancer Research UK Partnership Group (2018)
  • Disease Sub-Committee– (Vice Chair 2017-20)
  • Health & Care Research Wales
  • Grants Committee (2012)
  • Research for Patient & Public Benefit (Deputy Chair; 2013-18)
  • Health Fellowships Committee (2014)
  • Health Research Board Ireland
  • Joint Medical Research Charities Panel (2016, 2018)
  • Investigator Led Projects (Chair 2019)
  • Trials Methodology Research Network Review Panel (Chair 2021)
  • Medical Research Council UKRI
  • Infection & Immunity Board (2020-24)
  • COVID-19 Agile Panel (2020-21)
  • Welsh Government
  • Sêr Cymru II– College of Experts Independent Evaluation Panel (2015-18)

Editorial Boards
  • Journal Biological Chemistry (2015-20; 2022-27)
  • Frontiers in Immunology (Review Editor)
  • Function

Advisory Panels
  • Pharmaceutical companies
    • Roche/Chugai (tocilizumab); Sanofi-Regeneron (sarilumab); Janssen, EUSA Pharma (siltuximab); Ferring (olamkicept); NovImmune SA (NI-1201; NI-101).
  • Charities
    • Versus Arthritis, Senior Stakeholder Group
  • Government
    • Welsh Higher Education Brussels Board

Society Membership
  • International Cytokine & Interferon Society
  • Organiser of Cytokines2021 (Chair)
  • Development Committee - exploring industry links

Meetings Committee
  • Learned Society of Wales
  • The Royal Soc Biol
  • Brit Soc Immunology
  • Am Soc Mol & Cell Biol

Imprint Privacy policy « This page (revision-3) was last changed on Thursday, 1. July 2021, 12:46 by System
  • operated by